#NAOV hashtag - Bluesky

2 months ago

ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription ENvue Medical (NASDAQ: FEED) announced on January 14, 2026 the launch of over-the-counter ENFit syringes for enteral feeding and medication delivery, available without a prescription. The syringes will be sold in institutional and consumer-friendly packaging and are anticipated to appear at certain online retailers including Amazon and durable medical equipment suppliers. Offered in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes, the devices comply with ISO 80369-3 and are designed for reuse for up to seven days or 20 uses, aiming to support continuity of care across clinical and home settings.

#FEED #NAOV ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription

www.stocktitan.net/news/FEED/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

2 months ago

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a

#FEED #NAOV ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

www.stocktitan.net/news/FEED/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

2 months ago

ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 ENvue Medical (NASDAQ: FEED) will ring the Nasdaq Opening Bell at Nasdaq MarketSite in Times Square on Wednesday, January 14, 2026. The ceremony, led by Doron Besser, MD, CEO, will include company leadership, directors, employees, and key stakeholders. The event is scheduled for 8:30 A.M. – 9:45 A.M. ET at 151 West 43rd Street and will be available via live webcast.This public ceremonial event highlights the company’s focus on non-invasive enteral access and non-opioid pain management technologies and offers a visibility opportunity for investors and stakeholders to observe leadership remarks and company representation.

#FEED #NAOV ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026

www.stocktitan.net/news/FEED/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

3 months ago

ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK ENvue Medical (NASDAQ:NAOV) announced that the UroShield Kit was added to the UK NHS Drug Tariff Part IX on Dec 18, 2025, establishing a nationwide prescription reimbursement pathway.The company also secured an initial purchase order from Peak Medical, a UK distributor, providing early commercial demand signal and near-term revenue visibility heading into 2026. The UroShield Actuator was previously included in the Drug Tariff in 2023, and UroShield is intended to reduce catheter-associated urinary tract infections by applying low-frequency ultrasonic energy to catheters.

#NAOV ENvue Medical, Formerly NanoVibronix, UroShield® Kit Secures Reimbursement in the UK

www.stocktitan.net/news/NAOV/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

3 months ago

NHS to cover new device designed to cut catheter infections in the UK UroShield Kit joins NHS Drug Tariff Part IX, enabling UK-wide reimbursement as 6–7% of long-term care patients use catheters; distributor places first order.

#NAOV ENvue Medical’s UroShield® Kit Secures Reimbursement in the UK

www.stocktitan.net/news/NAOV/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

3 months ago

NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’ NanoVibronix (NASDAQ: NAOV) will change its corporate name to ENvue Medical and begin trading under the new ticker FEED at the open of market on December 12, 2025.The rebrand aligns the company with its primary focus on the ENvue feeding-tube placement system and a strategy to scale hospital utilization, expand commercial reach, and build an enteral-feeding ecosystem. No action is required from current stockholders and the company’s common-stock CUSIP remains unchanged.

#NAOV NanoVibronix, Inc. Announces Name and Ticker Symbol Change to ENvue Medical, Inc. and ‘FEED’

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

4 months ago

#NAOV NanoVibronix Issues Letter to Shareholders

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

5 months ago

Most Searched, Thursday October 9, 2025 – Crystal Equity Research

Most searched small-cap stocks, Thu Oct 9th - #RCAT #SERV #BAOS #LAES #NVTS #DVLT #USAR #WRD #ALIT #SRPT #TMQ #RAMP #NAOV #LUNR #FCEL #CRML #CERS #BTCS #GDRX #ATCH - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

Medical Tech Breakthrough: NanoVibronix's Oscar Platform Set to Transform Naso-enteral Training NanoVibronix introduces Oscar, a standardized training platform for naso-enteral feeding procedures. Launch targets teaching hospitals and nursing schools, with revenue generation starting 2026.

#NAOV NanoVibronix Launches “Oscar” Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

$2M Capital Raise: Medical Tech Company NanoVibronix Secures Funding Through Direct Share Offering Medical technology firm NanoVibronix (NAOV) secures $2M through sale of 291,204 shares at $7.01/share to institutional investor. Proceeds for working capital, debt repayment.

#NAOV NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

6 months ago

Most Searched, Monday September 15, 2025 – Crystal Equity Research

Most searched small-cap stocks, Mon Sept 15th - #RCEL #CLSK #IBRX #LDI #GPRO #GLUE #RZLV #ONDS #RIG #NAOV #HIVE #RXRX #NAKA #ATYR #WOLF #SBET #RR #QUBT #BITF #BBAI - More: crystalequityresearch.com/most-searche... - #smallcap

0 0 0 0

StockTitan

@stocktitan.net

6 months ago

Breakthrough Medical Navigation Patent: NanoVibronix's New Tech Makes Feeding Tube Placement Safer NanoVibronix's ENvue Medical subsidiary receives USPTO patent for electromagnetic positioning system to improve medical device insertion accuracy and patient safety in clinical procedures.

#NAOV NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

Game-Changing Medical Navigation Patent: NanoVibronix's Real-Time Imaging System Transforms Feeding Tube Placement NanoVibronix's subsidiary ENvue Medical receives US Patent 12,402,953 for real-time EM navigation overlay on medical imaging. Technology enhances feeding tube placement accuracy and enables vascular market expansion.

#NAOV NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

7 months ago

NanoVibronix Announces Major Share Restructure: 1:10 Reverse Split Cuts Outstanding Shares to 797K Medical device company reduces outstanding shares from 8M to 797K through reverse split. Trading continues on Nasdaq under NAOV. Get complete details.

#NAOV NanoVibronix Announces Reverse Stock Split

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

8 months ago

NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock NanoVibronix (NASDAQ: NAOV), a medical technology company, has secured a significant private placement financing of up to $50 million through convertible preferred stock. The deal includes an initial closing of $8 million and a second closing of $2 million through Series H Convertible Preferred Stock, with an initial conversion price of $1.01 per share.The agreement also provides the institutional investor with rights to purchase up to an additional $44 million in preferred stock over 36 months. The company plans to use $5 million from the initial proceeds to redeem outstanding Series X Preferred Stock, with the remainder allocated for working capital. Palladium Capital Group is serving as the exclusive placement agent for this transaction.

#NAOV NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

Market Wire News

@marketwirenews.com

9 months ago

News; ( NASDAQ: #NAOV ) PRISM Mid-Day Movers: Robotic Medical Innovation and Disappointing Earnings Diverge Indices

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

9 months ago

PRISM Mid-Day Movers: Robotic Medical Innovation and Disappointing Earnings Diverge Indices
#NanoVibronix Inc. ( #NAOV)
#AethlonMedical Inc. ( #AEMD)
#INmuneBio, Inc. ( #INMB)
#HeliusMedicalTechnologies, Inc. ( #HSDT)
#AdialPharmaceuticals, Inc. ( #ADIL)

prismmarketview.com/prism-mid-da...

0 0 0 0

𓂀 US Stock Pros ☥

@usstockpros.bsky.social

9 months ago

🚨 $NAOV on Watch!

✅ Hidden accumulation confirmed (OBV & ADL stable)
✅ High MFI = smart money inflow
✅ Approaching VWAP & key breakout zones
✅ Technical targets up to $2.17+

📈 Break above $1.21 could trigger a big move!
🎯 Eyes on – potential 50%-100% upside!

#Stocks #PreMarket #NAOV

1 1 0 0

StockTitan

@stocktitan.net

9 months ago

Healthcare Innovation: NanoVibronix Targets $10B Market with First AI-Powered Robotic Navigation System Revolutionary AI-robotic platform automates bedside medical procedures amid nurse shortages. See how this first-of-its-kind technology targets 10M+ annual procedures. Learn more.

#NAOV NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Medical Breakthrough: NY Hospital Adopts NanoVibronix's Advanced Feeding Tube Navigation Technology Major NY medical center implements cutting-edge electromagnetic navigation for safer feeding tube placement. Discover how this deal expands NanoVibronix's market presence. See Details

#NAOV NanoVibronix’s ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement

www.stocktitan.net/news/NAOV/nano-vibronix-...

0 0 0 0

PRISM MarketView

@prismmarketview.bsky.social

9 months ago

Why Are NAOV Shares Up 34% Today? Shares of NanoVibronix (NASDAQ: NAOV) jumped 34% following news that its subsidiary, ENvue Medical, has been granted a new U.S. patent for a pediatric feeding t

#NAOV shares surge 34% today! Investors are reacting to renewed interest in NeuroBo Pharmaceuticals following updates on its clinical pipeline and growth outlook.
#nanovibronix
prismmarketview.com/why-are-naov...

0 0 0 0

StockTitan

@stocktitan.net

9 months ago

Revolutionary Patent: ENvue Medical Targets 1.5M Annual Pediatric Procedures with Smart Feeding Tube Technology New electromagnetic tracking system eliminates X-rays for feeding tube placement in 400,000 preterm infants annually. FDA clearance pursuit underway. See clinical impact.

#NAOV ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System

www.stocktitan.net/news/NAOV/e-nvue-medical...

0 0 0 0

StockTitan

@stocktitan.net

10 months ago

NanoVibronix Announces CEO Transition NanoVibronix announced the immediate retirement of CEO Brian Murphy, who will remain as a director on the Board. Doron Besser, CEO of ENvue Medical Holdings (a subsidiary acquired by NanoVibronix in February 2025), has been appointed as the new CEO. The leadership transition follows NanoVibronix's strategic acquisition of ENvue, a company specializing in enteral feeding solutions. The merger aimed to combine strengths and create synergies in the medical device market. Chairman Christopher Fashek praised Murphy's contributions in driving product innovation and expanding distribution. Besser expressed optimism about capitalizing on new market opportunities and enhancing the product portfolio post-merger. The company remains focused on commercializing existing technologies while developing innovative medical solutions.

#NAOV NanoVibronix Announces CEO Transition

www.stocktitan.net/news/NAOV/nano-vibronix-...